{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:14:43Z","timestamp":1767150883281,"version":"build-2238731810"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR046494"],"award-info":[{"award-number":["R01 AR046494"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR060388"],"award-info":[{"award-number":["R01 AR060388"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/jid.2014.310","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T10:09:52Z","timestamp":1406023792000},"page":"170-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Suppressing AP1 Factor Signaling in the Suprabasal Epidermis Produces a Keratoderma Phenotype"],"prefix":"10.1016","volume":"135","author":[{"given":"Ellen A.","family":"Rorke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis R.","family":"Roop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.310_bb0010","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1167\/iovs.03-1180","article-title":"Regulation of involucrin expression in normal human corneal epithelial cells: a role for activator protein one","volume":"45","author":"Adhikary","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/jid.2014.310_bb0015","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1167\/iovs.05-0053","article-title":"Involucrin expression in the corneal epithelium: an essential role for Sp1 transcription factors","volume":"46","author":"Adhikary","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/jid.2014.310_bb0020","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/jid.2011.390","article-title":"Desmoglein as a target in skin disease and beyond","volume":"132","author":"Amagai","year":"2012","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0025","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1523-1747.1998.00343.x","article-title":"A novel insertional mutation in loricrin in Vohwinkel's Keratoderma","volume":"111","author":"Armstrong","year":"1998","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0030","first-page":"791","article-title":"Mechanism of action of a dominant-negative mutant of c-Jun","volume":"9","author":"Brown","year":"1994","journal-title":"Oncogene"},{"key":"10.1038\/jid.2014.310_bb0035","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archderm.1984.01650460063021","article-title":"Variant of keratoderma hereditaria mutilans (Vohwinkel's syndrome). Treatment with orally administered isotretinoin","volume":"120","author":"Camisa","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2014.310_bb0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrm1619","article-title":"The cornified envelope: a model of cell death in the skin","volume":"6","author":"Candi","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/jid.2014.310_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-9525(97)01104-9","article-title":"Frontiers in keratodermas: pushing the envelope","volume":"13","author":"Christiano","year":"1997","journal-title":"Trends Genet"},{"key":"10.1038\/jid.2014.310_bb0050","first-page":"848","article-title":"Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model","volume":"1","author":"Cooper","year":"2003","journal-title":"Mol Cancer Res"},{"key":"10.1038\/jid.2014.310_bb0055","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.onc.1205038","article-title":"The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation","volume":"21","author":"Crish","year":"2002","journal-title":"Oncogene"},{"key":"10.1038\/jid.2014.310_bb0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.jid.5700019","article-title":"The distal and proximal regulatory regions of the involucrin gene promoter have distinct functions and are required for in vivo involucrin expression","volume":"126","author":"Crish","year":"2006","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1432-0436.1993.tb00708.x","article-title":"Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype","volume":"53","author":"Crish","year":"1993","journal-title":"Differentiation"},{"key":"10.1038\/jid.2014.310_bb0070","doi-asserted-by":"crossref","first-page":"30460","DOI":"10.1074\/jbc.273.46.30460","article-title":"The distal regulatory region of the human involucrin promoter is required for expression in epidermis","volume":"273","author":"Crish","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1399-0004.2007.00914.x","article-title":"De novo occurrence of the 730insG recurrent mutation in an Italian family with the ichthyotic variant of Vohwinkel syndrome, loricrin keratoderma","volume":"73","author":"Drera","year":"2008","journal-title":"Clin Genet"},{"key":"10.1038\/jid.2014.310_bb0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/1523-1747.ep12336477","article-title":"The epidermis: genes on - genes off","volume":"109","author":"Eckert","year":"1997","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.0022-202X.2004.22723.x","article-title":"Regulation of involucrin gene expression","volume":"123","author":"Eckert","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0090","doi-asserted-by":"crossref","first-page":"34277","DOI":"10.1074\/jbc.M302759200","article-title":"A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1\/2 complex formation","volume":"278","author":"Efimova","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0095","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1128\/MCB.24.18.8167-8183.2004","article-title":"Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1\/2 complex","volume":"24","author":"Efimova","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1038\/jid.2014.310_bb0100","doi-asserted-by":"crossref","first-page":"31753","DOI":"10.1074\/jbc.M205098200","article-title":"Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p38 delta mitogen-activated protein kinase cascade that targets CCAAT\/enhancer-binding protein alpha","volume":"277","author":"Efimova","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0105","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1074\/jbc.275.3.1601","article-title":"Regulation of human involucrin promoter activity by novel protein kinase C isoforms","volume":"275","author":"Efimova","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0110","doi-asserted-by":"crossref","first-page":"24387","DOI":"10.1074\/jbc.273.38.24387","article-title":"Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38\/RK, AP1 signal transduction pathway","volume":"273","author":"Efimova","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2133.2005.06995.x","article-title":"Towards characterization of palmoplantar keratoderma caused by gain-of-function mutation in loricrin: analysis of a family and review of the literature","volume":"154","author":"Gedicke","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.310_bb0120","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1158\/0008-5472.CAN-06-1247","article-title":"Activator protein-1 activity regulates epithelial tumor cell identity","volume":"66","author":"Gerdes","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2014.310_bb0125","doi-asserted-by":"crossref","first-page":"e36941","DOI":"10.1371\/journal.pone.0036941","article-title":"Suppression of AP1 transcription factor function in keratinocyte suppresses differentiation","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/jid.2014.310_bb0130","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1016\/S0021-9258(18)38163-8","article-title":"Characterization of human loricrin. Structure and function of a new class of epidermal cell envelope proteins","volume":"266","author":"Hohl","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0923-1811(02)00143-3","article-title":"Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin","volume":"31","author":"Ishida-Yamamoto","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2014.310_bb0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00376822","article-title":"Loricrin immunoreactivity in human skin: localization to specific granules (L-granules) in acrosyringia","volume":"285","author":"Ishida-Yamamoto","year":"1993","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/jid.2014.310_bb0145","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1046\/j.1523-1747.2000.00163.x","article-title":"Mutant loricrin is not crosslinked into the cornified cell envelope but is translocated into the nucleus in loricrin keratoderma","volume":"115","author":"Ishida-Yamamoto","year":"2000","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/515518","article-title":"The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope","volume":"61","author":"Ishida-Yamamoto","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1038\/jid.2014.310_bb0155","first-page":"819","article-title":"Loricrin and human skin diseases: molecular basis of loricrin keratodermas","volume":"13","author":"Ishida-Yamamoto","year":"1998","journal-title":"Histol Histopathol"},{"key":"10.1038\/jid.2014.310_bb0160","first-page":"1245","article-title":"Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma","volume":"78","author":"Ishida-Yamamoto","year":"1998","journal-title":"Lab Invest"},{"key":"10.1038\/jid.2014.310_bb0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.jidsp.5640198","article-title":"Programmed cell death in normal epidermis and loricrin keratoderma. Multiple functions of profilaggrin in keratinization","volume":"4","author":"Ishida-Yamamoto","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0170","doi-asserted-by":"crossref","first-page":"42268","DOI":"10.1074\/jbc.M205593200","article-title":"Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families","volume":"277","author":"Jang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.0022-202x.2001.01661.x","article-title":"Quasi-normal cornified cell envelopes in loricrin knockout mice imply the existence of a loricrin backup system","volume":"118","author":"Jarnik","year":"2002","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.0022-202X.2004.23203.x","article-title":"Tetracycline-regulated transactivators driven by the involucrin promoter to achieve epidermal conditional gene expression","volume":"123","author":"Jaubert","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1067\/mjd.2002.124814","article-title":"The molecular basis of hereditary palmoplantar keratodermas","volume":"47","author":"Kimyai-Asadi","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.310_bb0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.151.2.389","article-title":"Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein","volume":"151","author":"Koch","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2014.310_bb0195","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/1523-1747.ep12337534","article-title":"Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis","volume":"109","author":"Korge","year":"1997","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0200","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/hmg\/8.7.1237","article-title":"A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families","volume":"8","author":"Maestrini","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1038\/jid.2014.310_bb0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0596-70","article-title":"A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome","volume":"13","author":"Maestrini","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2014.310_bb0210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1365-2133.2001.04412.x","article-title":"Loricrin keratoderma: a cause of congenital ichthyosiform erythroderma and collodion baby","volume":"145","author":"Matsumoto","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.310_bb0215","first-page":"1103","article-title":"Identification of a major keratinocyte cell envelope protein, loricrin","volume":"61","author":"Mehrel","year":"1990","journal-title":"J Cell Biochem"},{"key":"10.1038\/jid.2014.310_bb0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2230.2002.01031.x","article-title":"A recurrent mutation in the loricrin gene underlies the ichthyotic variant of Vohwinkel syndrome","volume":"27","author":"O'Driscoll","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1038\/jid.2014.310_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200708010-00001","article-title":"Acquired palmoplantar keratoderma","volume":"8","author":"Patel","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1038\/jid.2014.310_bb0230","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1468-3083.2007.02224.x","article-title":"Destructive deformation of the digits with auto-amputation: a review of pseudo-ainhum","volume":"21","author":"Rashid","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jid.2014.310_bb0235","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1038\/onc.2010.315","article-title":"AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation","volume":"29","author":"Rorke","year":"2010","journal-title":"Oncogene"},{"key":"10.1038\/jid.2014.310_bb0240","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.0022-202X.2004.22431.x","article-title":"Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis)","volume":"122","author":"Schmuth","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.310_bb0245","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.bbamem.2011.09.004","article-title":"Connexins in epidermal homeostasis and skin disease","volume":"1818","author":"Scott","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/jid.2014.310_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D316G809SF","article-title":"A new variant of Vohwinkel syndrome: a case report","volume":"17","author":"Seirafi","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1038\/jid.2014.310_bb0255","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2133.2008.08657.x","article-title":"A novel c.545-546insG mutation in the loricrin gene correlates with a heterogeneous phenotype of loricrin keratoderma","volume":"159","author":"Song","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.310_bb0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1083\/jcb.151.2.401","article-title":"Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma","volume":"151","author":"Suga","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2014.310_bb0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0923-1811(98)00049-8","article-title":"Loricrin gene mutation in a Japanese patient of Vohwinkel's syndrome","volume":"19","author":"Takahashi","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2014.310_bb0270","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1074\/jbc.270.21.12614","article-title":"Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity","volume":"270","author":"Welter","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0275","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1346-8138.2010.00932.x","article-title":"Expression of wild-type, but not mutant, loricrin causes programmed cell death in HaCaT keratinocytes","volume":"37","author":"Yoneda","year":"2010","journal-title":"J Dermatol"},{"key":"10.1038\/jid.2014.310_bb0280","doi-asserted-by":"crossref","first-page":"16184","DOI":"10.1074\/jbc.M109.056424","article-title":"Activation of vascular endothelial growth factor receptor 2 in a cellular model of loricrin keratoderma","volume":"285","author":"Yoneda","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0285","doi-asserted-by":"crossref","first-page":"18060","DOI":"10.1016\/S0021-9258(19)37152-2","article-title":"The human loricrin gene","volume":"267","author":"Yoneda","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2014.310_bb0290","doi-asserted-by":"crossref","first-page":"10754","DOI":"10.1073\/pnas.90.22.10754","article-title":"Overexpression of human loricrin in transgenic mice produces a normal phenotype","volume":"90","author":"Yoneda","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2014.310_bb0295","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/mc.10050","article-title":"Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun","volume":"34","author":"Young","year":"2002","journal-title":"Mol Carcinog"},{"key":"10.1038\/jid.2014.310_bb0300","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1073\/pnas.96.17.9827","article-title":"Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion","volume":"96","author":"Young","year":"1999","journal-title":"Proc Natl Acad Sci USA"}],"updated-by":[{"DOI":"10.1016\/j.jid.2021.05.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000}}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1537024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1537024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:45:09Z","timestamp":1743961509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1537024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0022202X1537024X"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.310","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppressing AP1 Factor Signaling in the Suprabasal Epidermis Produces a Keratoderma Phenotype","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}